Abstract | AIMS: MAIN METHODS: The M2 receptor transcript and protein expression was studied using RT-PCR and western blot analysis. (3)[H]- thymidine incorporation was used to evaluate cell proliferation in the presence or in the absence of M(2) agonist arecaidine. KEY FINDINGS: We demonstrated that M(2) receptor is expressed in both cell lines, although U251 cells show a higher expression level, compared to U87 cells. The activation of M(2) receptors by the agonist arecaidine decreases cell growth in a dose and time dependent manner. The anti-proliferative effect of arecaidine is also confirmed by the significant decrease of (3)[H]- thymidine incorporation in both cell lines. Moreover the M2 antagonist gallamine counteracts the arecaidine effects confirming M2 receptor involvement in glioma cell growth inhibition. SIGNIFICANCE: These data suggest a role for M2 receptors in the inhibition of glioma cell proliferation and the possibility of exploiting these receptors as new promising tools for glioblastoma therapy.
|
Authors | M Ferretti, C Fabbiano, M Di Bari, D Ponti, A Calogero, A M Tata |
Journal | Life sciences
(Life Sci)
Vol. 91
Issue 21-22
Pg. 1134-7
(Nov 27 2012)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 22575825
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Inc. All rights reserved. |
Chemical References |
- Receptor, Muscarinic M2
- arecaidine
- Arecoline
|
Topics |
- Arecoline
(analogs & derivatives, pharmacology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Gene Expression Regulation, Neoplastic
- Glioblastoma
(drug therapy, genetics, metabolism, pathology)
- Humans
- Receptor, Muscarinic M2
(agonists, antagonists & inhibitors, genetics, metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
|